Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
2003 1
2005 1
2006 1
2007 2
2008 1
2010 1
2011 7
2012 1
2013 3
2014 4
2015 3
2016 4
2017 2
2018 2
2019 1
2020 2
2021 6
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.
Stava TT, Leren TP, Bogsrud MP. Stava TT, et al. Eur J Prev Cardiol. 2022 Oct 18;29(13):1789-1799. doi: 10.1093/eurjpc/zwac102. Eur J Prev Cardiol. 2022. PMID: 35653365
Of the remaining 4396 probands, 65.1% were males, age at genetic testing was 50.9 (18.1) years and 6.1% were under the age of 18. A likely pathogenic or pathogenic variant (216 different variants including 67 novel) was detected in 574 probands, corresponding to a hit-rate …
Of the remaining 4396 probands, 65.1% were males, age at genetic testing was 50.9 (18.1) years and 6.1% were under the age of 18. A l …
Diagnosis and treatment of HCV heart diseases.
Haykal M, Matsumori A, Saleh A, Fayez M, Negm H, Shalaby M, Bassuony S. Haykal M, et al. Expert Rev Cardiovasc Ther. 2021 Jun;19(6):493-499. doi: 10.1080/14779072.2021.1917383. Epub 2021 Jun 2. Expert Rev Cardiovasc Ther. 2021. PMID: 33861939 Review.
A high prevalence of HCV infection has been noted in patients with hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy and myocarditis. ...
A high prevalence of HCV infection has been noted in patients with hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic
Genetic profile and genotype-phenotype correlations in childhood cardiomyopathy.
Wanert C, El Louali F, Al Dybiat S, Nguyen K, Zaffran S, Ovaert C. Wanert C, et al. Arch Cardiovasc Dis. 2023 Jun-Jul;116(6-7):309-315. doi: 10.1016/j.acvd.2023.04.008. Epub 2023 May 16. Arch Cardiovasc Dis. 2023. PMID: 37246080 Free article.
Patients were classified into six groups: hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; left ventricular non-compaction; arrhythmogenic right ventricular dysplasia; and mixed cardiomyopathy. ...There were no di …
Patients were classified into six groups: hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; left ventricul
Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
Alblaihed L, Kositz C, Brady WJ, Al-Salamah T, Mattu A. Alblaihed L, et al. Am J Emerg Med. 2023 Mar;65:146-153. doi: 10.1016/j.ajem.2022.12.010. Epub 2022 Dec 12. Am J Emerg Med. 2023. PMID: 36638611 Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder of the myocardium that can lead to ventricular arrhythmia and sudden cardiac death. ...
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder of the myocardium that can lead to vent
Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries.
Haugaa KH, Bundgaard H, Edvardsen T, Eschen O, Gilljam T, Hansen J, Jensen HK, Platonov PG, Svensson A, Svendsen JH. Haugaa KH, et al. Scand Cardiovasc J. 2015;49(6):299-307. doi: 10.3109/14017431.2015.1086017. Epub 2015 Sep 23. Scand Cardiovasc J. 2015. PMID: 26395672 Free PMC article. Review.
OBJECTIVES: Diagnostics of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) are complex, and based on the 2010 Task Force document including different diagnostic modalities. ...CONCLUSION: Careful follow-up is required in patients with ARV …
OBJECTIVES: Diagnostics of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) are complex, and based …
Advances in the Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM, Calkins H. Orgeron GM, et al. Curr Cardiol Rep. 2016 Jun;18(6):53. doi: 10.1007/s11886-016-0732-y. Curr Cardiol Rep. 2016. PMID: 27108363 Review.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy characterized by ventricular arrhythmias, right ventricular dysfunction, and sudden cardiac death. ...For instance, the discovery of
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited cardiomyopathy characterized
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
Protonotarios A, Bariani R, Cappelletto C, Pavlou M, García-García A, Cipriani A, Protonotarios I, Rivas A, Wittenberg R, Graziosi M, Xylouri Z, Larrañaga-Moreira JM, de Luca A, Celeghin R, Pilichou K, Bakalakos A, Lopes LR, Savvatis K, Stolfo D, Dal Ferro M, Merlo M, Basso C, Freire JL, Rodriguez-Palomares JF, Kubo T, Ripoll-Vera T, Barriales-Villa R, Antoniades L, Mogensen J, Garcia-Pavia P, Wahbi K, Biagini E, Anastasakis A, Tsatsopoulou A, Zorio E, Gimeno JR, Garcia-Pinilla JM, Syrris P, Sinagra G, Bauce B, Elliott PM. Protonotarios A, et al. Eur Heart J. 2022 Aug 21;43(32):3053-3067. doi: 10.1093/eurheartj/ehac235. Eur Heart J. 2022. PMID: 35766183 Free PMC article.
AIMS: To study the impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular cardiomyopathy (ARVC). METHODS AND RESULTS: The study cohort comprised 554 patients with a definite diagnosis of ARVC and no history of sustai …
AIMS: To study the impact of genotype on the performance of the 2019 risk model for arrhythmogenic right ventricular ca …
Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy.
Christensen AH, Platonov PG, Svensson A, Jensen HK, Rootwelt-Norberg C, Dahlberg P, Madsen T, Frederiksen TC, Heliö T, Haugaa KH, Bundgaard H, Svendsen JH. Christensen AH, et al. Europace. 2022 Feb 2;24(2):306-312. doi: 10.1093/europace/euab112. Europace. 2022. PMID: 34279601
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy (ARVC). We aimed at describing the complications associated with ICD treatment in a m …
AIMS: Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmoge
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.
Segura-Rodríguez D, Bermúdez-Jiménez FJ, Carriel V, López-Fernández S, González-Molina M, Oyonarte Ramírez JM, Fernández-Navarro L, García-Roa MD, Cabrerizo EM, Durand-Herrera D, Alaminos M, Campos A, Macías R, Álvarez M, Tercedor L, Jiménez-Jáimez J. Segura-Rodríguez D, et al. Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):378-386. doi: 10.1093/ehjci/jez277. Eur Heart J Cardiovasc Imaging. 2020. PMID: 31702781 Free article.
AIMS: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. ...Half of the patients were women, with a mean age of 41.6 17.5 years. Next-generation sequenc …
AIMS: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a hig …
Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
Protonotarios A, Anastasakis A, Panagiotakos DB, Antoniades L, Syrris P, Vouliotis A, Stefanadis C, Tsatsopoulou A, McKenna WJ, Protonotarios N. Protonotarios A, et al. Europace. 2016 Apr;18(4):610-6. doi: 10.1093/europace/euv061. Epub 2015 Mar 29. Europace. 2016. PMID: 25825460 Free PMC article.
AIMS: Arrhythmogenic right-ventricular cardiomyopathy (ARVC) is a genetically determined disorder, mostly caused by mutations in genes encoding desmosomal proteins. ...Repolarization abnormalities and left-ventricular dysfunction independently associat …
AIMS: Arrhythmogenic right-ventricular cardiomyopathy (ARVC) is a genetically determined disorder, mostly caused by mut …
49 results